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Themouse PERIOD1 (mPER1) protein, along with other clock proteins, plays a crucial role in the maintenance of circadian
rhythms. mPER1 also provides an important link between the circadian system and the cell cycle system. Here we show that the
circadian expression of mPER1 is regulated by rhythmic translational control of mPer1mRNA together with transcriptional
modulation. This time-dependent translation was controlled by an internal ribosomal entry site (IRES) element in the 5= un-
translated region (5=-UTR) of mPer1mRNA along with the trans-acting factor mouse heterogeneous nuclear ribonucleoprotein
Q (mhnRNPQ). Knockdown of mhnRNPQ caused a decrease in mPER1 levels and a slight delay in mPER1 expression without
changing mRNA levels. The rate of IRES-mediated translation exhibits phase-dependent characteristics through rhythmic inter-
actions betweenmPer1mRNA andmhnRNPQ. Here, we demonstrate 5=-UTR-mediated rhythmic mPer1 translation and pro-
vide evidence for posttranscriptional regulation of the circadian rhythmicity of core clock genes.
Circadian rhythms are produced by an endogenous clock sys-tem and are present in single-celled to complex organisms.
The principal circadian pacemaker is located in the suprachias-
matic nucleus (SCN) of the hypothalamus in mammals (33, 44).
Themammalianmolecular circadian clock system is composed of
feedback loops comprised of regulatory steps at the transcrip-
tional, translational, and posttranslational levels (31). These reg-
ulatory steps must be coordinated properly for the fine-tuning of
both amplitude and 24-h periodicity. In particular, posttranscrip-
tional regulation plays an important role, although its mechanism
is less well understood (17, 26, 29, 46, 47). One of the core clock
genes in mammals, Period1 (Per1), was originally identified as a
structural homologue of the Drosophila melanogaster circadian
clock gene per (42). The transcription of Per1 is activated by the
CLOCK-BMAL1 heterodimer (13, 20) and repressed by a com-
plex containing PER and cryptochrome (CRY) proteins (28), thus
comprising one of the core feedback loops. Although the molec-
ular function of mPER1 has not yet been defined, it is an essential
gene for the maintenance of circadian rhythm, because Per1
knockout mice show an altered period (2, 5, 52). mPER1 is
thought to be involved in resetting the circadian oscillator (1) and
to provide an important link between the circadian system and the
cell cycle system, such as cell growth and DNA damage control
(14). Interestingly, mouse Per1 (mPer1) expression is rhythmic,
but the phase of protein expression is delayed 6 to 8 h relative to
themRNA inmouse SCN (10), indicating thatmPER1 expression
may be regulated at a posttranscriptional step. This time lag be-
tween the mRNA and protein expression profiles has also been
observed in the Drosophila per gene (51), suggesting that these
time lags may be important for the clock system. Until now,many
researchers interested in circadian systems have focused on tran-
scriptional and posttranslational regulatory steps, with minor ef-
forts focused on posttranscriptional control, especially mRNA
stability. Moreover, the role of translational control in circadian
rhythmicity is not well understood. We hypothesized that circa-
dian phase-specific translational regulation of mPer1 mRNA
might be a novel mechanism for controlling mPER1 expression.
One mechanism of translational regulation is an internal ribo-
somal entry site (IRES)-mediated system. IRESs recruit ribosomes
directly in a cap-independentmanner, in contrast to the canonical
cap-dependent scanningmodel (12, 19, 43). Since the discovery of
viral IRESs (22, 37), various cellular mRNAs have been shown to
contain IRESs. IRES-mediated translation is used to regulate pro-
tein synthesis in certain physiological circumstances (41, 50), such
as apoptosis, cell cycle, development, and differentiation. Further-
more, IRES-mediated translation is important to nocturnal aryl-
alkylamineN-acetyltransferase (AANAT) protein synthesis in the
rat pineal gland (25). In contrast to canonical cap-dependent
translation, IRES-mediated translation can potentially be con-
trolled in various ways, such as in the presence of IRES trans-
acting factors (ITAFs), RNA secondary structures, RNA levels,
and in some cases, iron (38). ITAF is thought to function as an
RNA chaperone (38, 40). The binding of ITAF stabilizes a specific
IRES RNA conformation that enables the binding of other factors
or of the ribosome. Therefore, the binding of a specific combina-
tion of ITAFs on a target IRES in the 5= untranslated region (UTR)
could control the translation system.
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Plasmid constructions. mPer1 5=-UTRs (e1A and e1B) were amplified
from mPer1 cDNA using Pfu polymerase (Solgent) and confirmed by
sequencing. The resulting products were cloned into the SalI/SmaI site of
the intercistronic region of a pRF bicistronic vector containing Renilla
luciferase (Rluc) in the first cistron and firefly luciferase (Fluc) in the
second cistron (8, 23, 25). We used pRF, pHRF, and CMV RF vector
backbones (25). To create the deletion constructs pHRF144 and pHRF63,
mPer1 5=-UTR fragments were amplified from pRFe1A and pRFe1B and
then inserted into the SalI/SmaI site of the mock vector pHRF (25).
For the in vitro binding assay/UV cross-linking experiment, fragments
of themPer1 5=-UTRwere amplified, and the PCR products were digested
and subcloned into the EcoRI/XbaI site of the pSK= vector (24) to generate
pSK=-e1A, pSK=-e1B, pSK=-144, and pSK=-63.
To generate the bicistronic mRNA reporter for mRNA transfection,
pCY2-RFe1A, pCY2-RFe1B, and pCY2-RF63were constructed as follows:
the 5=-UTRs of mPer1 were cut from pRFe1A and pRFe1B using SalI/
BamHI and inserted into the SalI/BamHI site of pCY2-RF (6, 25).
Cell culture, isolationof embryonicfibroblasts, anddrug treatment.
HEK 293T cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; WelGENE) with 10% fetal bovine serum (HyClone) and 1%
antibiotics (WelGENE). NIH 3T3 cells were cultured inDMEMwith 10%
fetal bovine serum and 1% antibiotics and maintained in a humidified
95% air–5% CO2 incubator. Mouse embryonic fibroblasts (MEFs) were
isolated from trypsin-EDTA-digested embryonic day 13.5 (E13.5) em-
bryos (30). PrimaryMEFs were cultured in DMEM containing glutamine
but not Na-pyruvate (HyClone), with 1% antibiotics, 1% glutamine
(Gibco), 0.1% 2-mercaptoethanol (Gibco), and 10% fetal bovine serum.
The circadian oscillation of NIH 3T3 cells was synchronized by treatment
with 100 nM dexamethasone. After 2 h, the medium was replaced with
complete medium (4, 29, 46, 47). To block the translation system, NIH
3T3 cells were treated with 20 nM rapamycin or 100g/ml cycloheximide
(CHX) and then harvested at the indicated times.
Transient transfection and RNA interference. For expression of the
reporter constructs, HEK 293T and NIH 3T3 cells were seeded in 24-well
plates at a density of 5  104 cells per well 1 day prior to transfection.
Transfections were carried out using Metafectene (Biontex) according to
the manufacturer’s instruction. After incubation for 36 h, cells were har-
vested. The reporter mRNA transfection was performed as follows: NIH
3T3 cells were transiently transfected with 1 g of the capped bicistronic
reporter mRNA and incubated for 2 h. The medium was then exchanged
for completemedium, and the cells were incubated for a further 4 h. In the
study of time-dependent transfection, NIH 3T3 cells were treated with
dexamethasone and transiently transfected with 2 g of the capped bicis-
tronic reporter mRNA at intervals by using Lipofectamine 2000 (Invitro-
gen) and incubated for 6 h prior to harvest. Cell lysates were then prepared
and subjected to a luciferase assay or immunoblotting, Northern blotting,
or immunoprecipitation.
Small interfering RNA (siRNA; hnQ_si) was designed for endogenous
mouse heterogeneous nuclear ribonucleoprotein Q (mhnRNPQ) knock-
down. Mutated siRNA (hnQ_si_m) had changes in 3 nucleotides of
hnQ_si. The siRNA sequences are shown in Table S1 of the supplemental
material. For siRNA transfection intoNIH3T3 cells, amicroporator (Dig-
ital Bio/Invitrogen) was used as recommended by themanufacturer. After
12 h, dexamethasone treatment or reporter transfection was performed.
In vitro RNA synthesis, in vitro binding, UV cross-linking, and im-
munoprecipitation. For in vitro binding assays, [32P]UTP-labeled RNA
was transcribed from XbaI-linearized recombinant pSK= vectors with T7
RNApolymerase (Promega). FormRNA transfection, the bicistronic con-
structs pCY2-RFe1A and pCY2-RFe1Bwere linearizedwith EcoRI, as pre-
viously reported (25). This plasmid contains a 20-nucleotide (nt)-long
poly(A) stretch between the XhoI and EcoRI restriction sites. Reporter
mRNA was generated in vitro from the linearized plasmid with SP6 RNA
polymerase (Promega) in the presence of the ribo(m7G) cap analogue
(Promega). To identify proteins specifically bound to the mPer1 5=-UTR,
in vitro binding andUV cross-linking assays were performed as previously
described (25). Briefly, equal amounts of labeled RNAs were incubated
with 15 g nuclear extracts or 30 g cytoplasmic extracts of NIH 3T3 cell
for 20min. After incubation, the samples were UV irradiated on ice for 10
min with a CL-1000 UV cross-linker (UVP). Unbound RNAwas digested
with 5 l RNase cocktail (RNase A and RNase T1). The reaction mixtures
were analyzed by SDS-PAGE and autoradiography. For UV cross-linking
and immunoprecipitation, RNase-digested lysates were incubated with
specific antibodies or, for the negative control, preimmune serum. After
overnight incubation, protein G-agarose beads (Amersham Bioscience)
were added to the sample, which was further incubated for 3 h. Washed
beads were analyzed by SDS-PAGE and autoradiography.
Reporter assay, RNA quantification, and immunoprecipitation–re-
verse transcription (RT)-PCR (IP-PCR). The luciferase assay was per-
formed as previously described (25). The ratios betweenRenilla and firefly
luciferase activities (FLUC/RLUC) were calculated. The ratio for the
empty vector pRF was set to 1.
mRNA levels of endogenous or reporter plasmids were detected by
quantitative real-time PCR using a MyiQ single-color real-time detector
system (Bio-Rad) or a StepOnePlus real-time PCR system (Applied Bio-
systems) with the SYBR green mixture (Takara), as described previously
(29, 46, 47). Specific primer pairs for mPer1, mTbp, and firefly luciferase
were used for quantitative real-time PCR (the primer sequences are
shown in Table S2 of the supplemental material).
For IP-RT, we used a slightly modified method from that previously
reported (32, 48). The cytoplasmic extract was obtained as described pre-
viously (24). Immunoprecipitation was performed under RNase-free
conditions and carried out in immunoprecipitation buffer containing 125
mMKCl, 20mMHEPES (pH 7.4), 0.5mMEDTA, 0.05%NP-40, 0.5mM
dithiothreitol, RNasin (Promega), and protease inhibitor cocktail (Calbi-
ochem). RNA was extracted from the washed protein G-agarose bead
pellet with an RNA isolation solution (Molecular Research Center). Re-
verse transcription and quantitative real-time PCR were performed as
described above.
Immunoblot analyses. Immunoblot analyses were performed with
polyclonal anti-PER1, polyclonal anti-hnRNP Q (anti-SYNCRIP-N),
monoclonal anti-hnRNP Q (Sigma [for immunoprecipitation]), poly-
clonal anti-phospho-4EBP (Cell Signaling), polyclonal anti-actin (Santa
Cruz Biotechnology), monoclonal anti-glyceraldehyde-3-phosphate de-
hydrogenase (anti-GAPDH; Millipore), and monoclonal anti-14-3-3
(Santa Cruz Biotechnology) as primary antibodies. Horseradish
peroxidase-conjugated species-specific secondary antibodies (KPL) were
visualized using a SUPEX ECL solution kit (Neuronex) and a LAS-4000
chemiluminescence detection system (Fuji Film), and the acquired im-
ages were analyzed using Image Gauge (Fuji Film) according to the man-
ufacturer’s instructions.
Ribosomal profiling. Control or hnRNP Q-specific siRNA-trans-
fected NIH 3T3 cells were treated with cycloheximide (100 g/ml) for 5
min at 37°C and then harvested. Cell extracts were subjected to sucrose
gradient analysis, as previously described (9, 35). Total RNA of each frac-
tion was purified using TRI reagent (Molecular Research Center) and
subjected to real-time PCR analysis for quantification.
Statistical analyses. All quantitative data are presented as means 
standard errors of the means (SEM). To compare results between more
than two groups, we used a one-way analysis of variance with a post hoc
Tukey’s honestly significant difference test (IGOR Software). The crite-
rion for statistical significance was set at a P level of0.05.
RESULTS
Existence of an IRES element inmPer1mRNA. IRES-dependent
translation is mainly modulated by 5=-UTRs (12, 19, 43). In-
terestingly, mPer1 has two forms of 5=-UTRs, 183 bp (e1A) and
194 bp (e1B) (Fig. 1A), both consisting of two exons. The first
exons of the 5=-UTRs are different from each other, but the
second exons, which include the start codon, are the same.
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Both types of 5=-UTRs are the result of alternative promoter
usage, but the functional differences between the two are un-
known (49). To investigate the existence of an IRES in mPer1
mRNA, we inserted the 5=-UTRs of mPer1 into a bicistronic
reporter vector (Fig. 1A) (22, 25, 37, 43). The vector contained
a cytomegalovirus (CMV) promoter for direct transcription of
a bicistronic RNA encoding Renilla luciferase (Rluc) in the first
cistron and firefly luciferase (Fluc) in the second cistron. The
translation of Rluc from the first cistron is served by cap-
dependent translation, while the translation of Fluc reflects the
IRES activity of the inserted intergenic sequences. This system
is considered the gold standard in finding IRES elements. Both
5=-UTRs (e1A and e1B) enhanced the translation of Fluc more
than 8-fold compared to the control vector (Fig. 1B). These
results suggest that mPer1 mRNA contains a potential IRES
element within its 5=-UTR.We inhibited the mammalian target
of rapamycin (mTOR) pathway in NIH 3T3 cells (11, 24).
Rapamycin induces hypophosphorylation of eukaryotic initia-
tion factor 4E-binding proteins (4E-BPs), causing inhibition of
canonical cap-dependent translation (15, 18, 36, 39). When we
treated NIH 3T3 cells with rapamycin, the phospho-4E-BP
(p4E-BP) level was decreased, with no significant changes in
the level of mPER1 protein (Fig. 1C). However, the general
protein biosynthesis inhibitor CHX induced a dramatic de-
crease in mPER1 protein level. These results suggest that an
alternative translational system, other than cap-dependent
FIG 1 mPer1 has an IRES element. (A) Schematic diagram of bicistronic reporter plasmids containing the full-length 5=-UTRs of mPer1. The pRF bicistronic
reporter plasmid (pRF),Renilla luciferase, and firefly luciferase are shown. SV40, simian virus 40. (B)HEK293T cells were transiently transfectedwith bicistronic
reporter plasmids. The ratio of the empty vector pRF was set to 1 (n 5). , P 0.005639; , P 0.0005754. (C) Rapamycin (Rapa) or CHX-treated NIH
3T3 cells were harvested at the indicated time points (in h); then, the protein levels were checked by immunoblotting (IB). (D) Bicistronic vector systemwith no
CMV promoter. (E) Bicistronic vector that harbors a hairpin and loop. (F and G) The CMV promoter-deleted and hairpin-inserted reporter constructs were
transfected into HEK 293T cells, and a luciferase assay was performed. The activities of the pRF vector containing the full-length 5=-UTRs, as calculated based on
the FLUC/RLUC ratio, were set to 100. The results are expressed as the mean SEM of five independent experiments.
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translation, may be involved in maintaining the mPER1 pro-
tein level. The results also indicate that IRES-mediated trans-
lation plays a role in mPER1 production.
Confirmation of an IRES element inmPer1mRNA.Recently,
the notion of IRES-mediated translation of eukaryotic mRNA has
been challenged on the basis of the methods typically used for the
identification of IRES elements (27, 45). The result shown in Fig.
1B suggests that the 5=-UTRs of mPer1 mRNA may enhance the
read-through of ribosomes through the intergenic region, contain
IRES elements that enhance the translation of Fluc from the bicis-
tronicmRNA by internal initiation, or contain a cryptic promoter
or splicing acceptor site that creates a monocistronic transcript of
Fluc. To exclude any cryptic promoter activity of the mPer1 5=-
UTR, we removed the CMV promoter from bicistronic reporter
constructs (Fig. 1D). Because RLUC and FLUC activities were
measured from cells transfected with promoterless bicistronic
constructs, the expression levels of Rluc and Flucwere almost zero
(Fig. 1F andG,CMVRFe1A andCMVRFe1B). Based on these
results, we confirmed that the 5=-UTRs of mPer1 do not contain
cryptic promoters. To determine whether the effect of the mPer1
5=-UTRs on the translation of the second cistron is due to ribo-
some reinitiation, a synthetic hairpin loop was inserted upstream
ofRluc in both pHRFe1A and pHRFe1B (Fig. 1E). The insertion of
a hairpin loop reduced the expression of the first cistron, Rluc, by
80 to 90% compared to pRFe1A and pRFe1B, but the activity of
the second cistron, Fluc, produced by pHRFe1A and pHRFe1B
was not affected (Fig. 1F and G, pHRFe1A and pHRFe1B). This
argues against ribosome reinitiation as a possible mechanism.We
also confirmed the IRES of mPer1 in the mouse cell line NIH 3T3.
5=-UTRs of mPer1 enhanced the second cistron Fluc (see Fig. S1A
in the supplemental material). The insertion of a hairpin loop also
reduced Rluc but not Fluc, which are produced by pHRFe1A and
pHRFe1B (see Fig. S1B, C,D, and E in the supplementalmaterial).
Noncryptic promoter activities of mPer1 5=-UTRs were also con-
firmed in NIH 3T3 cells (see Fig. S1F and G). The RNA levels of
bicistronic reporters shown by quantitative RT-PCR or Northern
blotting confirmed that the induction of Fluc translation was not
caused by alteredmRNA stability, transcription, or the presence of
cryptic promoter activity or splice acceptors that producedmono-
cistronic products (see Fig. S2A and B). From these results, we
conclude that the 5=-UTRs of mPer1 mRNA have IRESs that can
directly initiate translation.
Existence of rhythmic IRES activity. To verify the function of
the mPer1 IRES under physiological conditions with circadian
rhythm, dexamethasone was applied to achieve synchronization
of circadian time in NIH 3T3 mouse fibroblasts (3, 29, 46, 47). In
dexamethasone-treated NIH 3T3 cells, we confirmed the oscilla-
tion of mRNA and protein and showed the time lag to be approx-
imately 8 h (Fig. 2A and B). To rule out any transcriptional or
posttranscriptional effects of the 5=-UTR, we generated a bicis-
tronic reporter mRNA (25) containing a cap structure for each
construct, RFe1A andRFe1B (Fig. 2C). The relative IRES activities
of constructs containing the 5=-UTRs were higher than that of the
reporter lacking a 5=-UTR (data not shown).When we transiently
transfected reporter mRNAs to dexamethasone-treated NIH 3T3
cells at certain time intervals, the IRES-mediated translation of
mPer1 seemed to be regulated rhythmically (Fig. 2D). This time-
dependent transfection did not change the endogenous circadian
rhythm (see Fig. S3 in the supplemental material). From these
results, we suggest that there is a rhythmic IRES-mediated trans-
lation ofmPer1mRNA thatmay be closely related to the circadian
expression of mPER1 protein.
mhnRNPQ specifically interacts with themPer1 5=-UTR.To
determine the cis-acting element of the mPer1 5=-UTR that is re-
sponsible for IRES activity, we generated reporter constructs con-
taining a truncated 5=-UTR of mPer1 mRNA (Fig. 3A). Because
mPer1 5=-UTRs contain two exons that have the same second
exon but different first exons, wemade the first exon-deleted con-
struct containing the second exon and only 10 nt of the first exon
(Fig. 3A, construct 144). We also deleted 80 nt from the 144 con-
structs on the basis of the RNA secondary structure (Fig. 3A, con-
struct 63) and then inserted the truncated 5=-UTRs of mPer1 into
the pHRF vector. The pHRF63 deletion construct exhibited 60 to
70% decrease in Fluc activity compared to controls (pHRFe1A
and pHRF e1B), yet the Rluc activity was similar among all con-
structs (Fig. 3B and C). These results suggest that the region be-
tween the 144 and 63 constructs in themPer1 5=-UTR is important
for IRES function.
Generally, IRES-mediated translation requires ITAFs that reg-
ulate ribosome recruitment, which ultimately determines cap-
independent translation efficiency (41, 43). We assumed that
ITAFs might bind to the cis-acting element for IRES function of
the mPer1 5=-UTR. To analyze the relationship between mPer1
IRES function and the binding patterns of cellular proteins, we
performed UV cross-linking assays. All 5=-UTRs, wild-type (e1A
and e1B) and deleted constructs (144 and 63) bound to some
cytoplasmic cellular proteins in a similar manner (Fig. 3D).
Among them, a 68-kDa protein (p68) showed strong binding to
full-length e1A, e1B, and deletion construct 144, but not to dele-
tion construct 63 (Fig. 3D, lane 4), which showed weak IRES ac-
tivity. The binding patterns of p68 were also similar when nuclear
protein extracts were used for the UV cross-linking assay (see Fig.
S4A in the supplemental material). We previously reported the
function of mhnRNP Q as an ITAF and 3=-UTR-binding protein
involved in IRES-mediated translation andmRNA degradation in
the expression of AANAT (24, 25). To test whether p68 is
mhnRNP Q, immunoprecipitation of UV cross-linked proteins
with radiolabeled, in vitro-transcribed 144 and 63 RNA (Fig. 3E,
lanes 1 and 2) was performed using anti-mhnRNP Q antibody.
mhnRNP Q was immunoprecipitated from the UV cross-linked
proteins by its specific antibody (Fig. 3E, lane 3). No bands were
detected when anti-Flag antibody was used as a negative control
(Fig. 3E, lane 4). To confirm the direct interaction between hn-
RNP Q and the 5=-UTR of mPer1, radiolabeled 5=-UTR and puri-
fied hnRNP Q were subjected to in vitro binding and UV cross-
linking. Purified hnRNP Q protein was shown to directly interact
with the mPer1 5=-UTR (Fig. 3F). We also confirmed that the
binding of mhnRNPQ to the 5=-UTR of mPer1mRNA is specific,
because the binding was markedly reduced by the addition of
mPer1 5=-UTR 144 RNA competitors (see Fig. S4B in the supple-
mentalmaterial). Knockdown of hnRNPQdecreased direct bind-
ing between hnRNP Q and the mPer1 5=-UTR (see Fig. S4C). On
the basis of these results, we concluded that the 68-kDa protein is
mhnRNP Q and directly binds to the mPer1 5=-UTR.
mhnRNP Q as an IRES trans-acting factor of mPer1mRNA.
mhnRNP Q is involved in various aspects of mRNA metabolism,
such as pre-mRNA splicing (34),mRNAdegradation (16, 24), and
cellular IRES-mediated translation (25). Because mhnRNP Q
strongly bound to the wild-type 5=-UTR and the 144 region of
mPer1 mRNA, but not the truncated 63 region, which exhibited
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insignificant IRES activity, we thought that mhnRNP Q might be
one of the ITAFs of mPer1 mRNA. To validate the role of
mhnRNP Q in mPer1 mRNA translation, we used a knockdown
system employing siRNA againstmhnRNPQ (hnQ_si) and amu-
tated siRNA (hnQ_si_m) that did not decreasemhnRNPQ levels.
NIH 3T3 cells were transiently transfected with control siRNA
(Con_si), hnQ_si_m, and hnQ_si; 12 h later, reporter constructs
containing the 5=-UTR of mPer1 were transfected. hnQ_si mark-
edly decreased mhnRNP Q protein levels, but Con_si and
hnQ_si_m did not (Fig. 4A). Knockdown of the mhnRNPQ level
decreased both forms of IRES activity of mPer1mRNA (Fig. 4B).
We confirmed the effects and concentration dependencies of
hnQ_si and hnQ_si_m siRNAs (see Fig. S5 in the supplemental
material). Thus, mhnRNP Q may play an important role as an
ITAF in activating IRES-mediated translation of mPer1.
To analyze the physiological role of IRES-mediated translation
of mPer1 by mhnRNP Q in circadian expression, we used the
knockdown approach in NIH 3T3 cells. Reduction of mhnRNPQ
resulted in lowermPER1protein levels (Fig. 4C andD), suggesting
that mhnRNP Q is critical for mPer1 mRNA translation. Previ-
ously, we showed that hnRNP Q functions as a 3=-UTR-binding
factor important for mRNA stability (24). Thus, we determined
whether reduced mPER1 levels due to knockdown of mhnRNPQ
were caused bymPer1mRNAdegradation.WhenmhnRNPQwas
decreased, the oscillation pattern, amplitude, and phase of mPer1
mRNAwere not dramatically changed (Fig. 4E). These data imply
that decreased mPER1 protein due to decreased mhnRNP Q is
mediated by reduced translational activity rather than transcrip-
tional or posttranscriptional modulation. Furthermore, the de-
creased IRES activity due to reduced mhnRNP Q mediated the
diminished and delayedmPER1 expression. Taken together, these
results imply that the IRES activity ofmPer1 bymhnRNPQallows
robust expression of mPER1 in relation to the circadian period.
The importance of hnRNP Q in mPer1mRNA translation was
further investigated by analyzing the distribution patterns of con-
trol mGapdhmRNA and mPer1mRNA in ribosome profiles with
FIG2 Existence of rhythmic IRES activity. (A) The oscillation pattern of themPER1protein as shownbyWestern blotting (WB).NIH3T3 cells were treatedwith
dexamethasone; then, cells were subjected to immunoblotting at the indicated time points. (B) In the case of the mPER1 protein profile, the data from panel A
were quantified. By using the same cell extracts as those for which results are shown in panel A, mPer1mRNA levels were checked by quantitative real-time PCR.
(C) Schematic diagram of the bicistronicmRNA reporter ofmPer1 5=-UTRs; 7-methyl-guanosine (m7G) and the 20-nt-long poly(A) tail [poly(A)20] are shown.
(D) NIH 3T3 cells were treated with 100 nM dexamethasone and transiently transfected with bicistronic mRNA reporters (full-length Per1 5=-UTRs e1A or e1B
or a truncated Per1 5=-UTRwhich has no IRES activity and no interaction with hnRNPQ [construct 63]) for 6 h at the indicated times and subjected to luciferase
assays. Relative IRES activities were calculated and plotted for e1A and e1B IRESs and for construct 63, which has no IRES activity.
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or without hnRNP Q knockdown (Fig. 5A and B). The overall
profiles of ribosomes in sucrose gradient analyses were not altered
by decreased hnRNPQ. This was reflected in the levels of a control
mGapdhmRNA. The distribution pattern of mGapdhmRNAwas
not changed by knockdown of hnRNP Q (Fig. 5C). On the other
hand, a shift ofmPer1mRNA fromheavy polysome (fraction 4) to
light polysome (fraction 3), reflecting a reduction in mPer1
mRNA translation, was observed in cells transfected with siRNA
against hnRNP Q (Fig. 5D). These results suggest that hnRNP Q
plays an important role in the translation of mPer1mRNA.
Rhythmic binding between mhnRNP Q and mPer1 mRNA.
As shown in Fig. 2D, the IRES-mediated translation rate followed
the circadian period.mhnRNPQ levels could be rhythmic to allow
circadian IRES activity, but the level of mhnRNP Q was relatively
constant (Fig. 4C). In fact, themhnRNPQ levels in the cytosol and
the nucleus were unchanged during the circadian time (see Fig. S6
in the supplemental material). We wondered if the interaction
between mhnRNP Q and mPer1 mRNA is rhythmic. To test
our hypothesis, we performed a UV cross-linking assay with
dexamethasone-treated cell extracts. The binding affinity was cor-
related with the mPER1 protein phase (Fig. 6A). To confirm the
rhythmic interaction between mhnRNP Q and mPer1mRNA, we
performed IP-RT (32, 48) by using mhnRNP Q antibody after
dexamethasone treatment of NIH 3T3 cells. The immunoprecipi-
tated mhnRNP Q levels and input levels were the same during
their respective circadian time frames (Fig. 6B). Interestingly,
mPer1 mRNA, which coimmunoprecipitated with mhnRNP Q,
changed with dexamethasone treatment time, but mTbp mRNA
did not (Fig. 6C). In addition, mPer1mRNAs, which were coim-
munoprecipitated, had peak levels at 32 h, whichwas also the peak
time of mPER1 protein expression. mPer1mRNAwas not immu-
noprecipitated using preimmune serum (data not shown), indi-
FIG 3 hnRNP Q specifically interacts with the mPer1 5=-UTR. (A) Schematic diagram of the serially deleted mutation strategy. (B) Each bicistronic deletion
construct derived from the e1A full-length 5=-UTR was transfected into HEK 293T cells. The graph shows the relative luciferase activities derived from the
FLUC/RLUC ratio. The activities of pHRFe1A were set at 100. (C) Results for an experiment similar to that shown in panel B, but with the 5=-UTR derived from
e1B. (D) 5=-UTRs transcribed in vitro were subjected to in vitro binding and UV cross-linking with a CHO-K1 cytoplasmic extract. The arrow indicates the
68-kDa protein, showing differential binding. (E) Cytoplasmic extracts labeled by UV cross-linking with radiolabeled 5=-UTRs of mPer1 were subjected to
immunoprecipitation with antibodies against hnRNP Q (lane 3) or Flag (lane 4) as a control and then separated by SDS-PAGE for autoradiography. (F)
Cytoplasmic extracts or purified hnRNP Q were used for UV cross-linking. All results are expressed as the mean SEM of five independent experiments.
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cating that mhnRNP Q rhythmically binds to mPer1 mRNA in a
specificmanner andmediates time-dependent translational activ-
ity. However, treatment with dexamethasone causes mPer1
mRNA to oscillate, and abundant mPer1mRNA at peak time (24
h) may bind to more mhnRNP Q compared to less mPer1mRNA
at trough time. To exclude the possibility that rhythmic binding
between mPer1mRNA and mhnRNP Q was affected by changing
mPer1 mRNA levels, we used reporter mRNAs (Fig. 2C) to
maintain constant mRNA levels. We transiently transfected
dexamethasone-treated NIH 3T3 cells at the indicated times with
the 5=-UTR of mPer1 mRNA reporters and then performed IP-
RT. The levels of immunoprecipitated mhnRNP Q were the same
at all time points (Fig. 6D). Nevertheless, coimmunoprecipitated
mRNA reporter levels were different at each time point (Fig. 6E).
The time point showing higher levels of reporter mRNAs that
coimmunoprecipitated with mhnRNP Q correlated with the
mPER1 peak time. Therefore, the results suggest that rhythmic
binding betweenmhnRNPQandmPer1mRNA leads to circadian
time-dependent IRES-mediated translation regardless of mPer1
mRNA or mhnRNP Q protein levels.
Functional role of mhnRNP Q. To analyze the relationship
between mhnRNP Q and mPer1 mRNA in primary tissues, we
determined the protein levels of mhnRNP Q and mPER1 in
mouse liver. mPER1 protein levels were rhythmic to circadian
time, but mhnRNP Q levels were relatively constant across time
points (Fig. 7A). Cytosolic fractions of mouse liver were used for
FIG 4 hnRNPQ as an IRES trans-acting factor of mPer1mRNA. (A) The cell extracts (10g) used for the experiment summarized in panel B were subjected to
Western blotting. (B) siRNAs that target mhnRNP Q (hnQ_si), mutated mhnRNP Q siRNA (hnQ_si_m), and control siRNA (Con_si) were transfected with
bicistronic reporters to NIH 3T3 cells. The activities of transfected cells with Con_si were set to 1 (n  4). For pHRFe1A, P  0.04551; for pHRFe1B, P 
0.007797. (C) NIH 3T3 cells were transfected with siRNAs targeting mhnRNP Q or control siRNA by microporation, incubated for 12 h, treated with
dexamethasone, and harvested at the indicated time points. Then, immunoblotting (IB) was performed with the indicated antibodies. (D) The relative levels of
mPER1 in panel C, normalized to 14-3-3, were calculated and plotted. The mPER1 level at 36 h, normalized to 14-3-3, was set to 100. (E) Total RNA was
prepared from the harvested cells for which data are shown in panel D, and thenRT and real-time PCRwere performedwith anmPer1-specific primer. Error bars
represent the mean SEM of triplicate measurements.
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in vitro binding and UV cross-linking with the radiolabeled 5=-
UTR of mPer1. Surprisingly, binding between hnRNP Q and e1A
RNA correlated with the mPER1 protein phase as the circadian
rhythm (Fig. 7B). These results suggest that rhythmic binding be-
tween mhnRNP Q and mPer1 mRNA leads to circadian time-
dependent IRES-mediated translation regardless ofmPer1mRNA
ormhnRNPQprotein levels and is as relevant in cultured cell lines
as in animal tissues.
DISCUSSION
Periodicity of transcription is essential formaintaining the cycle of
a molecular clock system. Posttranscriptional and posttransla-
tional regulations also appear to be important for fine-tuning such
a system. In the expression of mPer1, there is a time lag between
the mRNA oscillation pattern and the protein expression profile.
To explain this phenomenon, posttranscriptional regulation was
considered part of the mechanism. Recently, the importance of
posttranscriptional regulation in the bio-clock system has
emerged (7, 24–26, 29, 46, 47). Indeed, it has been reported that
circadian-regulated rat AANAT expression is controlled by IRES-
mediated translation (25). Translation initiation, in concert with
transcription, could be a critical step for gene expression. We fo-
cused on the translation initiation step for posttranscriptional reg-
ulation of the bio-clock system, using mPer1 as an example.
mPER1 is an important clock protein that is part of the core feed-
back loop in the circadian rhythm system.mPER1 is thought to be
essential for maintaining circadian rhythm and phase resetting.
PER1 is also linked to cell cycle regulation and cancer.
In the present study, we found that the 5=-UTR of mPer1 con-
tained an IRES element and that its translation rate was circadian
time dependent. As other clock genes also have rhythmic mRNA
and protein profiles with time lag, we also checked their IRES
activities: mouse cryptochrome 1 (mCry1), mouse Period2
(mPer2), and mouse Period3 (mPer3) (see Fig. S7 in the supple-
mental material). mPer1 5=-UTRs have high IRES activities, but
not mCry1, mPer2, or mPer3. In the cases of mPer2 and mPer3,
IRES activities were slightly increased above controls but were
much lower than for mPer1. However, these results must be con-
firmed by other experiments. We think that some other mecha-
nisms also can modulate their expression and can create time lag
oscillation of clock genes. It has been reported that LARK regu-
lates mPer1 translation through binding to the 3=-UTR of mPer1
(26).mPER1 expression is regulated via 3=- and 5=-UTR-mediated
translation. To clarify themechanism of rhythmicmPER1 expres-
sion, more information, such as activity of LARK protein under
the condition of mhnRNP Q knockdown, the collective effects of
LARK andmhnRNPQonmPER1, expression time, and the bind-
ing pattern of hnRNP Q and LARK are required.
mhnRNP Q directly bound to the 5=-UTR of mPer1 mRNA,
while a construct that could not bind to mhnRNP Q had little
IRES activity. Indeed, knockdown of mhnRNP Q inhibited the
IRES activity of mPer1 and resulted in decreased mPER1 protein
expression without changing mPer1 mRNA levels. We examined
the cycling of anmPer2-dsLuc reporter in dexamethasone-treated
cells, with control siRNAor hnRNPQsiRNA transfection (see Fig.
S8A in the supplemental material). Knockdown of hnRNP Q,
which reduces mPER1 protein, did not change the period of
mPer2-dsLuc activity. To check the effects of hnRNP Q in detail,
we also observed endogenous mRNA profiles of clock genes. A
decrease in the hnRNP Q level did not change the mouse D site
albumin promoter-binding protein (mDbp) or mCry1 mRNA
FIG 5 Knockdown of hnRNPQ results in redistribution of mPer1 RNAs in a ribosomal profile. (A and B) NIH 3T3 cells were transfected with control (Con_si)
or hnRNP Q-specific siRNA (hnQ_si). After 24 h of incubation, the cells were treated with cycloheximide. Then, the ribosomal distributions in sucrose density
gradients were analyzed in cell extracts. RNA samples were purified from fractions in the sucrose gradient. (C andD)Distribution ofmRNA in sucrose gradients.
The amounts ofmGapdhmRNA(C) andmPer1mRNA(D) across the gradientwere analyzed by real-time PCR, and the relative amounts of RNA in each fraction
are depicted by corresponding bars in the graphs.
Lee et al.













rhythm (see Fig. S8B and C). However, knockdown of hnRNP Q
slightly reduced the mRNA level of mouse nuclear receptor sub-
family 1 (mNr1d1) andmPer2 (see Fig. S8D andE). The possibility
that hnRNPQmodulates other clock genes should be considered.
We found that hnRNP Q could directly bind to the 3=-UTR of
mCry1 (data not shown). As hnRNP Q binds to mRNA of mPer1
and other clock genes, the knockdown of hnRNPQ ormPer1may
lead to a different outcome. Tounderstand the function of hnRNP
Q in the overall clock system, further studies of the core clock
protein levels and the relationship between hnRNP Q and other
clock genes would be necessary.
At first, we thought that the mhnRNP Q protein level might
follow a circadian rhythm because it was shown to be rhythmic in
rat pineal glands (25). However, rather than the mhnRNP Q pro-
tein itself exhibiting circadian rhythm, it was the interaction be-
tweenmhnRNPQandmPer1mRNA that was rhythmic, and their
FIG 6 Rhythmic binding of mhnRNP Q to mPer1 mRNA. (A) Dexamethasone-treated cytoplasmic cell extracts of NIH 3T3 cells were subjected to in vitro
binding and UV cross-linking with the radiolabeled mPer1 144 5=-UTR. The cytoplasmic cell extracts used for UV cross-linking were also subjected to
immunoblotting (IB), using 14-3-3 as a control. The band intensities were quantified. (B)NIH3T3 cells were treatedwith dexamethasone, and cytosolic extracts
were prepared. Immunoprecipitation (IP) was performed using anti-hnRNP Q antibody and preimmune serum as a control. (C) The coimmunoprecipitated
mRNAs with mhnRNP Q shown in panel B were analyzed by real-time PCR. (D) NIH 3T3 cells were treated with dexamethasone, and bicistronic mRNA
reporters that harbor 5=-UTRs of mPer1were transfected at the indicated time points and subjected to immunoprecipitation. (E) Two-thirds (based on volume)
of the washed beads from the immunoprecipitation in panel D were used for total RNA preparation. Then, the RNA level was quantified by real-time PCR with
Fluc-specific primers and normalized to the Fluc value obtained in the preimmunoprecipitation experiment. The relative numerical values at 17 to 23 h were set
to 1 (n 4). Means and SEM (error bars) are shown. , P 0.005.
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binding was strongest at peak mPER1 levels. It is not known why
the expression profile of mhnRNP Q is different from previous
results with rat pineal glands (25).mhnRNPQmay oscillate in the
pineal gland but not in other tissues or cells. A further study to
elucidate the mechanism of rhythmic mhnRNP Q binding to
mPer1 mRNA is needed. The secondary structure of mPer1
mRNA at different circadian times or the interaction of mhnRNP
Q with other unknown ITAFs in a time-dependent manner may
affect the rhythmic binding ofmhnRNPQ tomPer1mRNA. Post-
translational modification of mhnRNP Q, such as phosphoryla-
tion, may also have an effect on the rhythmic interaction.
mhnRNP Q may be phosphorylated on a tyrosine residue. It has
been shown that the binding of RNA to mhnRNP Q specifically
inhibited mhnRNP Q phosphorylation (21). We assume that
rhythmic phosphorylation of mhnRNP Q may be one of the
mechanisms allowing a time-dependent interaction between
mhnRNP Q and mPer1mRNA.
Because mPer1 has two 5=-UTR forms as a result of alternative
promoter usage, any functional differences between the 5=-UTRs
should be clarified. Based on transfection with DNA reporters
(Fig. 1B), the two 5=-UTRs have different IRES activities. How-
ever, the IRES activities were similar, and the difference was small
when mRNA reporters were transfected (data not shown). We
think the discrepancy between the DNA and RNA transfection
activities is due to a low cryptic promoter activity or a posttran-
scriptional effect.
Based on our data, the oscillation of mPER1 levels can be ex-
plained as illustrated in our model (Fig. 7C). mhnRNPQ binds to
preexisting mPer1 mRNAs. Then, mhnRNP Q facilitates the re-
cruitment of ribosomes, which accelerates IRES-mediated trans-
lation of mPer1; mPER1 protein then reaches peak levels. How-
ever, modifications in mhnRNP Q or a change in the ITAF
complexmay preventmhnRNPQbinding tomPer1mRNAs. This
may bring about inefficient cap-independent translation, causing
the mPER1 protein level to decrease. The present study revealed a
new mechanism of rhythmic IRES-mediated mPer1 translation
that may be an important step in the regulation of the circadian
clock. This system may induce fine-tuning of the expression time
and amplitude of mPER1 regardless of mRNA oscillation. A sim-
ilar circadian time-dependent translation may be functional in
FIG7 The functional role ofmhnRNPQ and a summarymodel.Mice were sacrificed at the indicated times (n 6 for each time interval). (A) Liver extracts were
subjected to immunoblotting (IB) with the indicated antibodies. (B) Cytoplasmic extracts of liver were subjected to in vitro binding and UV cross-linking with
a radiolabeled 5=-UTR e1A or construct 63; immunoblotting was also performed. (C) Proposed model for rhythmic translation of mPer1 as a key regulatory
mechanism of circadian mPER1 expression. mhnRNPQ, alone or with other ITAFs, strongly binds to mPer1mRNA and accelerates IRES-mediated translation
of mPer1. At other times, modifications in mhnRNP Q or its association with other ITAFs may inhibit interaction between mhnRNP Q and mPer1mRNA. The
weak binding of mhnRNP Q to mPer1mRNA could not enhance cap-independent translation of mPer1, and only canonical cap-dependent translation could
produce mPER1. For this reason, the mPER1 protein level is low.
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other core clock genes. From these results, we suggest that the
physiological circadian rhythm is generated by a very complex
rhythmic molecular system that comprises time-dependent tran-
scriptional, rhythmic posttranscriptional, andmodulated transla-
tional and posttranslational regulation. This work may help to
explain the time gap between mRNA and protein regulation of
amplitude and phase. Our study may also ultimately give insight
into the tightly and finely regulatedmolecular system of the circa-
dian clock.
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